13F filing recap · Q4 2012

What did Polen Capital Management buy in Q4 2012?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Polen account, including accounts that belong to no fund below.

Stock value

$4.27B

Positions

Estimated turnover

—

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

AAPLApple Inc.$356.35Mreported value+669.6K shares CTSHCognizant Technology Solutions Corporation$317.26Mreported value+4.29M shares GOOGLAlphabet Inc.$302.68Mreported value+427.9K shares QCOMQualcomm Inc/de$294.39Mreported value+4.76M shares TROWPrice T Rowe Group Inc$270.66Mreported value+4.16M shares SBUXStarbucks Corporation$260.80Mreported value+4.86M shares AGNAllergan Inc$253.29Mreported value+2.76M shares ABTAbbott Laboratories$248.55Mreported value+3.79M shares NKENike, Inc.$237.68Mreported value+4.61M shares INTUIntuit Inc.$229.79Mreported value+3.86M shares ISRGIntuitive Surgical, Inc.$229.36Mreported value+467.7K shares MSFTMicrosoft Corporation$224.29Mreported value+8.40M shares ORCLOracle Corporation$222.81Mreported value+6.69M shares ACNAccenture Plc$219.08Mreported value+3.29M shares VARVarian Medical Systems, Inc.$213.84Mreported value+3.04M shares FDSFactset Research Systems Inc.$182.12Mreported value+2.07M shares CHRWC.h. Robinson Worldwide, Inc.$121.27Mreported value+1.92M shares GWWW.w. Grainger, Inc.$84.72Mreported value+418.6K shares